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Zinc Calixarene Complexes for the Ring Opening Polymerization of 
Cyclic Esters 
Mark J. Walton,a Simon J. Lancaster,a Joseph A. Wright,a Mark R.J. Elsegoodb and Carl Redshawc* 
Reaction of Zn(C6F5)2·toluene (two equivalents) with 1,3-dipropoxy-p-tert-butyl-calix[4]arene (L1H2) 
led to the isolation of the complex [{Zn(C6F5)}2L1] (1), whilst similar use of Zn(Me)2 resulted in the 
known complex [{Zn(Me)}2L1] (2). Treatment of L1H2 with in-situ prepared Zn(N(SiMe3)2)2 in 
refluxing toluene led to the isolation of the compound  [ZnN(SiMe3)2L1(Na)] (3). The stepwise reaction 
of L1H2 and sodium hydride, followed by ZnCl2 and finally NaN(SiMe3)2 yielded the compound 10 
[Zn(N(SiMe3)2)2L1] (4). The reaction between three equivalents of Zn(C6F5)2·toluene and 
oxacalix[3]arene (L2H3) at room temperature formed the compound {[Zn(C6F5)]3L2} (5); heating of 5 in 
acetonitrile caused the ring opening of the parent oxacalix[3]arene and rearrangement to afford the 
complex [(L2)Zn6(C6F5)(R)(RH)OH·5MeCN] R = C6F5CH2–(p-tBuPhenolate–CH2OCH2–)2–p-
tBuPhenolate–CH2O-)3- (6). The molecular structures of the new complexes 1, 3 and 6, together with that 15 
of the known complex 2, whose solid state structure has not previously been reported, have been 
determined. Compounds 1, 3 – 5 have been screened for the ring opening polymerization (ROP) of ε-
caprolactone (ε-CL) and rac-lactide. Compounds featuring a Zn—C6F5 fragment were found to be poor 
ROP pre-catalysts as they did not react with benzyl alcohol to form an alkoxide. By contrast, compound 
4, which contains a zinc silylamide linkage, was the most active of the zinc-based calix[4]arene 20 
compounds screened and was capable of ROP at ambient temperature with 65 % conversion over 4 h. 
Introduction 
A great number zinc-based ring opening polymerization (ROP) 
catalysts have been explored since the seminal work by Coates 
and co-workers.1 The majority of these catalysts employ ligand 25 
systems such as diphenolates,2, 3 or  Schiff bases,4 whilst 
relatively few calixarene-based catalysts for the ROP of either 
lactides or lactones have been examined.5 Generally, ligands that 
are monoanionic are chosen for reaction with zinc precursors as 
they will inevitably lead to a metal that still contains a viable 30 
nucleophilic group for ROP, which may be the reason that p-tert-
calix[4]arenes have rarely been utilized. Vigalok and co-workers 
have had success with zinc alkyl-based calix[4]arenes and 
although the dialkoxycalix[4]arene ligand is dianionic when 
deprotonated its use leads to a dimetallic complex that can still 35 
contain a nucleophilic group.6 Indeed, in related work, we have 
accessed a highly selective and immortal magnesium based 
mononuclear complex [L3Mg(n-Bu)], where L3 is derived from 
tripropoxy-p-tert-butylcalix[4]arene, which exhibited exceptional 
activity for the ROP of rac-lactide.7 Given zinc compounds are 40 
often synthesized due to their higher tolerance of water,8 we have 
initiated a programme to more fully explore both the coordination 
chemistry and catalysis of zinc-based calixarenes. Herein, we 
explore the use of the calix[4]arene ligand L1H2 and the oxacalix- 
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Chart 1. Ligands utilized herein. 45 
[3]arene ligand L2H3 (see Chart 1).9 Resulting zinc compounds 
have been subjected to both ε-caprolactone and rac-lactide ROP 
studies. The effect of additional chain transfer agents are 
described, and the tacticity of the resulting polymers are 50 
discussed. 
Results and discussion 
Calix[4]arene Complexes 
A number of new zinc-containing calix[4]arene complexes have 
been synthesised and fully characterized. The synthetic 55 
procedures are outlined below in Scheme 1. 
Scheme 1 Synthesis of zinc compounds 1 – 4.  i) 2 Zn(C6F5)2.tol, toluene, reflux, 16 h. ii) 2 ZnMe2, toluene, RT, 16 h. iii) 1) 2 NaH, THF, 16 h, room 
temperature, 2) ZnCl2, THF, 2 h, RT, 3) Na(N(SiMe3)2), THF, 2 h, RT. iv) 2 Zn(N(SiMe3)2)2,  toluene, reflux, 72 h.
The compound 1,3-dipropoxy-p-tert-butyl-calix[4]arene (L1H2) 5 
was synthesized as previously described.10,11 Treatment of L1H2 
with Zn(C6F5)2·toluene (two equivalents) in refluxing toluene 
led to the isolation of the complex [{Zn(C6F5)}2L1] (1) in good 
yield (54 %). A related n-propoxy calix[4]arene derivative, 
synthesized via treatment with ZnMe2, was previously employed 10 
by Vigalok and co-workers, who reported that calix[4]arene 
derivatives containing smaller alkyl chains (at the lower rim) led 
to more complex products, including partial and 1,3-alternate 
cone conformations.12 In the case of 1, the cone conformation 
was isolated exclusively. Crystallization of compound 1 using hot 15 
acetonitrile led to the formation of clear blocks on slow cooling 
to ambient temperature, which proved suitable for single crystal 
X-ray diffraction studies. Compound 1 crystallises with two 
different pentafluorophenyl zinc environments, one outside of the 
calix[4]arene backbone and the other within the cavity. The exo 20 
zinc metal centre is five co-ordinate in a trigonal bipyramidal 
geometry bonding to all four of the calix[4]arene lower-rim 
oxygens, whereas the encapsulated zinc is trigonal planar and 
only binds to the ‘non-propoxy’ oxygen atoms. The structure of 
compound 1 is depicted in Figure 1, with selected bond lengths 25 
and angles given in the caption. 
Disappointingly, the pre-polymerization screening of compound 
1 indicated no reaction between the benzyl alcohol (BnOH) and 
the Zn—C6F5 moiety, which was also the conclusion obtained by 
Schnee et al and Piedra-Arroni et al when Zn(C6F5)2·toluene 30 
was employed in the presence of either BnOH or 
amine/phosphine respectively.13,14 In such systems, the catalyst 
was thought to behave as a ‘monomer activator’ rather than 
proceeding via a ‘co-ordination insertion’ pathway; the lack of 
activity contrasts with a number of previous Zn—C6F5 35 
containing compounds.13,14 To ensure that the polymerization 
would proceed through a ‘co-ordination insertion’ mechanism, 
the   
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Figure 1 ORTEP representation of compound 1. Hydrogen atoms, tert-
butyl groups and minor disordered components have been removed for 
clarity. Displacement ellipsoids are drawn at the 50 % probability level. 
Selected bond lengths (Å) and angles (°): Zn(1)—O(1) 2.346(2), Zn(1)—5 
O(2) 1.968(2), Zn(1)—O(3) 2.312(2), Zn(1)—O(4) 1.964(2), Zn(2)—O(2) 
1.956(2), Zn(2)—O(4) 1.931(2), Zn(1)—C(57) 1.948(13), , Zn(2)—C(51) 
1.944(3), O(4)—Zn(1)—O(2) 79.16(8), O(4)—Zn(2)—O(2) 80.26(8), 
Zn(2)—O(2)—Zn(1)  99.78(8),  Zn(2)—O(4)—Zn(1) 100.80(8).  
pentafluorophenyl moiety was substituted for a more nucleophilic 10 
group. To isolate a zinc alkoxide, firstly the methyl zinc 
derivative (compound 2) was synthesized following the literature 
procedure.6 Single crystals of compound 2 suitable for single 
crystal X-ray diffraction were grown from a saturated petroleum 
ether solution. The structure of 2 was initially assigned based on 15 
1H NMR spectroscopic data and is similar to the ethyl derivative.6 
Surprisingly, the crystal structure of 2 (See Figure 2) reveals both 
the cone and partial cone conformations within the unit cell 
(although the partial cone is better described as a chair 
conformation); the 1H NMR spectrum (CDCl3) indicates that 20 
only the cone conformation is present in solution, which is 
consistent with the literature data.6 
The cone conformation of 2 is similar to that observed in 
compound 1, and again the exo-Zn is trigonal bipyramidal, whilst 
the endo-Zn is trigonal planar. In the chair conformation, there is 25 
a centre of inversion in the middle of the calix[4]arene. The zinc 
metal centres are in the base of a trigonal pyramid with the n-
propoxy oxygen at the apex.  
Treatment of 2 with alcohol (MeOH, iPrOH) at −80 °C did not 
form the alkoxide; only starting material was detected. At higher 30 
temperatures, free calix[4]arene was formed, suggesting that the 
alcohol displaced the calix[4]arene; a similar result was reported 
by Drouin et al.15 
Zinc silylamides have previously been shown to be active for 
ROP of L-lactide and as such the synthesis of a calix[4]arene zinc 35 
silylamide was targeted. Treatment of L1H2 with 
Zn(N(SiMe3)2)2, which was synthesized in situ, from the sodium 
salt, in refluxing toluene led to the isolation of compound 3. 
Rather than the expected formation of a dizinc silylamide species, 
where one Zn—N(SiMe3)2 fragment is present in the cavity, 40 
compound 3 contains a sodium cation within the cavity. The 
sodium cation likely originates from unreacted sodium 
hexamethyldisilazane. 
45 
Figure 2 ORTEP representation of compound 2. Hydrogen atoms, tert-butyl groups and minor disorder components have been removed for clarity. 
Displacement ellipsoids are drawn at the 50 % probability level. Selected bond lengths (Å) and angles (°): Cone: C(51)—Zn(1) 1.942(5), C(52)—Zn(2) 
1.955(5), O(1)—Zn(1) 1.972(3), O(1)—Zn(2) 1.978(3), O(2)—Zn(1) 1.970(3), O(2)—Zn(2) 1.984(3), O(4)—Zn(2) 2.360(3), Zn(1)—O(1)—Zn(2) 101.26(14), 
Zn(1)—O(2)—Zn(2) 101.12(13), O(2)—Zn(1)—O(1) 78.95(13), C(52)—Zn(2)—O(1) 139.96(19), C(52)—Zn(2)—O(2) 141.36(19), O(1)—Zn(2)—O(2) 
78.47(13). Partial Cone: C(78)—Zn(3) 1.941(6), O(5)—Zn(3) 1.981(4), O(5)—Zn(3)i 1.985(4), O(6)—Zn(3) 2.211(3), Zn(3)—O(5)i 1.985(4), Zn(3)—O(5)—50 
Zn(3)i 104.49(16), O(5)—Zn(3)—O(5)i 75.51(16), O(5)—Zn(3)—O(6) 86.70(13), O(5)i—Zn(3)—O(6) 90.36(14). 
Figure 3 ORTEP representation of compound 3. Hydrogen atoms, tert-
butyl groups and disorder have been removed for clarity. Displacement 
ellipsoids are drawn at the 50 % probability level. Selected bond lengths 
(Å) and angles (°): Zn(1)—N(1) 1.8929(13), Zn(1)—O(1) 1.9297(10), 5 
Zn(1)—O(3) 1.9402(10), Zn(1)—O(2) 2.2760(10), N(1)—Zn(1)—O(1) 
131.42(5), N(1)—Zn(1)—O(3) 134.32(5), O(1)—Zn(1)—O(3) 88.46(5), 
N(1)—Zn(1)—O(2) 109.26(5), O(1)—Zn(1)—O(2) 87.08(4), O(3)—Zn(1)—
O(2) 91.34(4). 
Single, rod-like, crystals were obtained on prolonged standing of 10 
a petroleum ether solution of 3 at ambient temperature. The 
crystal structure was determined by X-ray diffraction (Figure 3). 
The zinc centre is bound to three of the oxygens of the calixarene, 
the two phenolic oxygens and one n-propoxy oxygen. As 
expected, the dative O—Zn bond length is significantly longer 15 
than the other two, viz 2.2760(10) vs. 1.9297(10) and 1.9402(10) 
Å; the N—Zn bond is 1.8929(13) Å. The sodium cation occupies 
the calix[4]arene cavity and is π-bonded to two opposite aryl 
rings, both η6. The Na(1) to centroid distances are 2.741 and 
2.607 Å. The interaction between the sodium cation and one of 20 
the η6-centroids causes a pinching of the calixarene so that the 
final OR group is far enough removed that it does not participate 
in dative bonding to the zinc; the latter is therefore in the base of 
a trigonal pyramid rather than in the trigonal bipyramidal 
geometry seen for 1. The sodium and zinc centres are 3.1725(7) 25 
Å apart. The target dizinc silylamide, compound 4, was 
synthesized from the reaction between two equivalents of zinc 
bis(hexamethyldisilyl amide), which has been vigorously 
separated, and L1H2 in toluene. Attempts to crystalize the product 
from THF/light petroleum, acetonitrile and pentane were 30 
unsuccessful; the compound was exceptionally soluble in these 
solvents. The volatiles from the reaction were removed in vacuo 
to give a yellow solid. The 1H NMR spectrum, elemental analysis 
and mass spectrum all match the structure as depicted in Scheme 
1. The 1H NMR spectrum is consistent with the calix[4]arene 35 
possessing a cone conformation and is similar to the recorded 
spectrum for 1.  
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Chart 2. Oxacalixarene complexes 5 and 6. 
Oxacalix[3]arene complexes 40 
For comparison we have prepared the related oxacalixarene 
complexes. The reaction between three equivalents of 
Zn(C6F5)2·toluene and oxacalix[3]arene (L2H3) at room 
temperature led to the formation of compound 5 after removal of 
volatiles. However, on attempted crystallisation from hot 45 
acetonitrile, ring opening of the parent oxacalix[3]arene and 
rearrangement to complex 6 was observed. The ability of an 
electrophilic species to open the ether linkages of the oxacalix 
backbone is not unprecedented, for example Iglesia and co-
workers proposed a similar product from a Ti/SiO2 grafted 50 
oxacalix[3]arene,17 however this is the first structurally 
characterised result.  
Unfortunately, suitable single crystals of compound 5 could not 
be obtained. The 1H NMR spectra are consistent with the 
complex existing in a partial cone conformation: there are three 55 
distinct sets of doublets for each of the methylene bridges and 
there is a two to one integration for the two discrete tert-butyl 
peaks. The 19F NMR spectra also show a two to one integration 
for each of the ortho- and para-fluorine signals; the meta-fluorine 
signals overlap. Compound 5 has also been characterised by mass 60 
spectroscopy and elemental analysis, both of which are consistent 
with the structure depicted in chart 2. 
The structure of the ring opened oxacalix[3]arene compound 6 
was determined by single crystal X-ray diffraction, which 
revealed the presence of three separate oxacalix[3]arene ligands 65 
within the molecule, two of which have been ring opened with 
formation of two carbon—C6F5 bonds and a protonated oxygen 
which is involved either in hydrogen bonding to an acetontrile 
molecule or an oxygen anion that forms two short bonds with two 
Zn2+ centres (See Figure 4). The remaining oxacalix[3]arene 70 
remains intact. There are six zinc metal centres within the 
compound, one of which is bound to a C6F5 ring. The core of the 
molecule consists of two Zn3O4 cubes missing one corner, linked 
via two O atoms and supported with an O—H···O H-bond (see 
Table 1). The resulting 1H NMR spectrum is complex due to lack 75 
of symmetry 
Figure 4 ORTEP representation of compound 6 (left) and the core of compound 6 (right). Hydrogen atoms except for those participating in hydrogen 
bonding in the core of compound 6 (H19), tert-butyl groups, solvent molecules and minor disorder components have been removed for clarity. 
Displacement ellipsoids are drawn at the 50 % probability level. Selected bond lengths (Å): Zn1—O1 1.966(8), Zn1—C37 1.999 (13), Zn1—O3 2.047 (8), 
Zn1—O2 2.156(8), Zn1—O8 2.241(7), Zn2—O7 1.942 (8), Zn2—O4 2.014 (8) Zn2—O3 2.040 (7), Zn2—O5 2.043 (9), Zn2—O8 2.101(8), Zn3—O8 2.019 (9), 
Zn3—O6 2.047 (8), Zn3—O10 2.099(8), Zn3—O5 2.105 (8), Zn3—O9 2.147(8), Zn3—O1 2.270 (7), Zn4—O19 2.029(8), Zn4—O13 2.051(10), Zn4—O10 5 
2.065(8), Zn4—O12 2.071 (8), Zn4—O14 2.120 (9), Zn5—O7 1.941 (7), Zn5—O14 1.968 (8), Zn5—O16 2.027(8), Zn5—O19 2.042 (8), Zn5—O15 2.154 (9), 
Zn6—O18 1.895 (8), Zn6—O12 2.015(9), Zn6—O16 2.021(8), Zn6—O19 2.025 (8), Zn6—O17 2.132(8).  
with nine separate tert-butyl signals. The 19F NMR spectrum 
consists of nine peaks in total for the three C6F5 fragments.  
10 
Table 1. Hydrogen-bond geometry (Å, º) for 6 
 D—H•••A D—H H•••A D•••A  D—H•••A 
O19—H19•••O5 1.00 1.84 2.786 (11) 157
Polymerization Screening 15 
Compounds 1, 3 – 5 were screened for the polymerization of ε-
caprolactone (ε-CL) and rac-lactide. The results are presented in 
Table 1. 
Compound 1 was screened for the polymerization of ε-
caprolactone at room temperature and was found to be inactive 20 
when using dichloromethane, tetrahydrofuran or toluene as 
solvent (Table 2, runs 1 – 3). Only at temperatures greater than 80 
°C was compound 1 found to be active for the ROP of ε-
caprolactone; attempting polymerization without benzyl alcohol 
present was detrimental to the catalytic system (Table 2, runs 5 – 25 
7). Furthermore, compound 1 was only active for the ROP of rac-
lactide at high temperature. In both cases (ε-caprolactone and 
rac-lactide) high conversion rates can be achieved at high 
temperature, however the resulting polymer molecular weight is 
much lower than expected; this indicates that there are significant 30 
trans-esterification reactions occurring at such temperatures. 
Screening of compound 4, where the C6F5 groups have been 
replaced with N(SiMe3)2, revealed that the system was active at 
room temperature and converted 100 equivalents of ε-
caprolactone with 65 % completion over 4 h in toluene (Table 2, 35 
run 13). The polymer molecular weights were close to the 
expected values; lower activity was observed using THF. This 
compares favourably with the ROP activity (43 % over 24 h at 60 
oC) observed for the hexanuclear complex 
[L2(ZnEt)4Zn2(CH3CN )4(µ-OEt)2].9a 40 
Compound 3, which differs from compound 4 by replacement of 
the Zn—N(SiMe3)2 in the calix[4]arene cavity with a sodium 
cation, was not active under the same conditions as for 4. 
Compound 5 was only active for the ROP of rac-lactide and ε-
caprolactone at high temperatures (100 °C) and gave ε-45 
caprolactone molecular weight much lower than expected. The 
polymerization using 5 was further complicated due to the 
probability of forming a species similar to compound 6; the latter 
was not screened for polymerization. Interestingly, despite the 
aforementioned trans-esterification at high temperatures, all of 50 
the zinc compounds screened afforded products with low PDI 
values (1.06 – 1.48). We also note that for the 
[L2(ZnEt)4Zn2(CH3CN )4(µ-OEt)2]9a the use of low co-catalyst 
loadings resulted in molecular weights far lower than the 
calculated values, indicating the importance of back biting 55 
reactions. Similarly for [L2(ZnEt)4Zn2(CH3CN )4(µ-OEt)2]9a, 
the polydispersity (≤ 1.3) was not hampered by such back biting. 
Experimental 
All manipulations were carried out under an atmosphere of 60 
nitrogen using standard Schlenk and cannula techniques or in a 
conventional nitrogen-filled glove-box. Solvents were refluxed 
over an appropriate drying agent, and distilled and degassed prior 
to use. Elemental analyses were performed by the microanalytical 
services at London Metropolitan University. NMR spectra were 65 
recorded on Bruker Ascend 500/300 MHz spectrometers at 298 
K; chemical shifts are referenced to the residual protio impurity 
of the deuterated solvent. IR spectra (Nujol mulls) were recorded 
on Perkin-Elmer 577 and 457 grating spectrophotometers. L1H2 
and L2H3 were synthesized by the reported procedures.10,18 rac-
Lactide was purchased from Sigma Aldrich and used without 
further purification. GPC analysis was performed on a Polymer 
Laboratories, PL-GPC 50 using THF at 0.5 mL′min flow rate and 5 
30 °C, corrected by the Mark-Houwink factor (0.58). 
Table 2 ROP of ε-caprolactone/rac-lactide using zinc compounds 1, 3 – 5. 
Run Pre- Cat Solvent Monomer T (°C) M : BnOH Time (h) Conva (%) Mn ,GPC Mn,Cal PDI 
1 1 Toluene ε-caprolactone 20 25 : 1 24 - 
2 1 THF ε-caprolactone 20 25 : 1 24 - 
3 1 CH2Cl2 ε-caprolactone 20 25 : 1 24 - 
4  1 Toluene ε-caprolactone 60 25 : 1 24 - 
5  1 Toluene ε-caprolactone 80 25 : 1 3 96 
6  1 Toluene ε-caprolactone 100 25 : 0 2 95 
7 1 Toluene ε-caprolactone 100 25 : 1 1 98 
8  1 Toluene ε-caprolactone 100 100 : 1 3 85 4,760 9,700 1.06 
9  1 Toluene ε-caprolactone 100 200 : 1 4 90 7,600 20,500 1.48 
10  3 THF ε-caprolactone 20 100 : 1  24 21 
11  3 Toluene ε-caprolactone 20 100 : 1 24 21 
12  4 THF ε-caprolactone 20 100 : 1  4 27 
13  4 Toluene ε-caprolactone 20 100 : 1 4 65 11,900 7,920 1.27 
14 4 Toluene ε-caprolactone 20 100 : 2 4 49 4,740 2,800 1.27 
15 4 Toluene ε-caprolactone 20 200 : 4 4 47 4,500 2,680 1.18 
16 5 Toluene ε-caprolactone 20 100 : 1 24 - 
17 5 Toluene ε-caprolactone 40 100 : 1 24 - 
18 5 Toluene ε-caprolactone 80 100 : 1 2 77 2,800 8,800 1.07 
19 5 Toluene ε-caprolactone 100 100 : 1 1 95 2,970 10,800 1.11 
20 1 Toluene rac-lactide 100 100 : 1 3 90 (Pr  = 0.62) 1,440 13,000 1.26 
21 4 Toluene rac-lactide 20 100 : 1 5 64 (Pr  = 0.54) 8,970 9,220 1.13 
22 5 Toluene rac-lactide 100 100 : 1 3 52 
 
Conditions: Polymerisation carried out using 60 μmol catalyst at 20 °C, [Monomer]0 = 0.6 M, 10 mL solvent, ROH taken from a ROH/toluene solution. a 
Determined by NMR spectroscopy, b Calculated from ([Monomer]0/[OH]0) x conv.(%) x Monomer molecular weight + ROH. Mn GPC values corrected 10 
considering Mark-Houwink factors (0.58 polylactide/0.56 poly(ε-caprolactone)) from polystyrene standards in THF.19,20  
Synthesis of L1(ZnC6F5)2 (1) 
1,3-dipropoxy-p-tert-butylcalix[4]arene (0.75 g, 1.0 mmol) and 
bis(pentafluorophenyl)zinc.toluene (0.98 g, 2.0 mmol) were 
dissolved in toluene (30 ml) and refluxed for 16 h. The volatiles 15 
were removed in vacuo. The residue was extracted into warm 
acetonitrile and after 24 h clear blocks of 1 formed. (0.65 g, 54 
%). MS (EI, m/z) 1196 [M]+, 1181 [M-Me+]. Found: C, 62.06; H, 
5.42. C62H66F10O4Zn2 requires C, 62.27; H, 5.56 %. IR (ATR, 
cm-1): 2953m, 1738m, 1632w, 1505m, 1457s, 1363m, 1256m, 20 
1203m, 1097w, 1074m, 1056m, 986m, 953s, 917w, 831w, 755m, 
721w, 526m. 1H NMR (CDCl3): 7.13 (s, 4H, Ar-H), 6.83 (s, 4H, 
Ar-H), 4.43 (d, 4H, J = 17.5, endo-CH2), 3.82 (t, 4H, J = 10.0 Hz, 
OCH2CH2CH3), 3.39 (d, 4H, J = 17.5, exo-CH2) 1.54 (m, 4H, 
CH2CH2CH3), 1.39 (s, 18H, C(CH3)3), 0.68 (m, 24H, C(CH3)325 
+ CH2CH2CH3). 19F (CDCl3): -113.9 (m, 2F, o-ArF), -114.0 (m, 
2F, o-ArF) -154.8 (t, 1F, J = 19.3, p-ArF), -158.0 (t, 1F, J = 19.3, 
p-ArF), -160.5 (m, 2F, m-ArF), -164.4 (m, 2F, m-ArF). 
Synthesis of L1[NaZnN(SiMe3)2] (3) 
1,3-dipropoxy-p-tert-butylcalix[4]arene (2.00 g, 2.73 mmol) and 30 
sodium hydride (140 mg, 5.83 mmol) were dissolved in THF (30 
ml).  The solution was stirred for 1 h and then ZnCl2 (0.37 g, 
2.73 mmol) was added as a THF solution (15 ml). The solution 
was stirred for a further 1 h, NaN(SiMe3)2 (2.73 ml, 1 M solution 
in THF) was then added and after 1 h, the volatiles were removed 35 
in vacuo. The residue was extracted in petroleum ether and on 
standing (2 h) clear rods of compound 3 formed. (1.32 g, 50 %). 
MS (EI, m/z): 977 [M+]. Found: C, 68.44; H 8.72; N, 1.49. 
C56H84NNaO4Si2Zn requires C, 68.65; H, 8.64; N, 1.43 %. IR 
(ATR, cm-1): 2954s, 2903m, 2870m, 1453s, 1350m, 1301m, 40 
1249m, 1194m, 1097w, 995m, 930s, 872m, 839s, 752m. 1H 
NMR (CDCl3): δ = 7.13 (s, 4H, Ar-H), 6.70 (s, 2H, Ar-H), 6.67 
(s, 2H, Ar-H), 4.38 (d, 2H, J = 13.1, endo-CH2), 4.32 (d, 2H, J = 
12.9, endo-CH2), 4.26 (t, 2H, J = 8.02, OCH2), 3.77 (t, 2H, J = 
7.80, OCH2CH2CH3), 3.18 (d, 2H, J = 13.1, exo-CH2CH2CH3), 45 
3.13 (d, 4H, J = 12.7, exo-CH2), 1.99 (m, 2H, J = 7.68, 
OCH2CH2CH3), 1.46 (m, 2H, J = 7.62, OCH2CH2CH3), 1.39 (s, 
9H, C(CH3)3), 1.37 (s, 9H, C(CH3)3), 0.97 (s, 9H, C(CH3)3), 
0.94 (s, 9H, C(CH3)3), 0.91 (t, 3H, J = 7.00, OCH2CH2CH3), 
0.52 (t, 3H, J = 7.28,  OCH2CH2CH3), 0.11 (s, 18H, N(SiMe3)2. 50 
13C NMR (CDCl3): δ = 162.5, 157.3, 154.0, 153.5, 136.9, 136.0, 
132.1, 131.6, 125.5, 125.4, 123.3, 122.2, 78.1, 77.5, 34.2, 34.0, 
33.9, 33.7, 33.7, 32.4, 32.1, 31.4, 31.3, 23.0, 22.5, 10.1, 9.5, 5.5, 
2.7. 
Synthesis of L1[ZnN(SiMe3)2]2 (4) 55 
1,3-dipropoxy-p-tert-butylcalix[4]arene (2.00 g, 2.73 mmol) was 
dissolved in toluene (30 ml) and zinc 
bis(bis(trimethylsilyl)amide) (2.20 ml, 5.46 mmol) was added. 
The solution was heated at reflux for 72 h. The volatiles were 
removed in vacuo and the residue extracted with pentane. The 60 
pentane solution was concentrated to 15 ml and left to stand 
overnight resulting in a yellow microcrystalline solid 4. (1.39 g, 
43 %) MS (EI, m/z) 1022 [M-ZnN(TMS)2+]. Found: C, 63.12; H 
8.68; N, 2.22. C62H102N2NaO4Si2Zn requires C, 62.97; H, 8.69; 
N, 2.37 %. IR (ATR, cm-1): 2955s, 2905m, 2869m, 1478s, 65 
1390m, 1361m, 1303m, 1250m, 1194s, 1124w, 1096w, 995m, 
966s, 931s, 870s, 827s, 799m, 754m. 1H NMR (CDCl3): δ = 7.03 
(s, 4H, Ar-H), 6.76 (s, 4H, Ar-H), 4.50 (d, 4H, J = 12.1, endo-
CH2), 4.06 (t, 4H, J =7.46, OCH2CH2CH3), 3.16 (d, 4H, J = 
12.1, exo-CH2), 1.91 (m, 4H, J = 7.47, OCH2CH2CH3), 1.28 (s, 70 
18H, C(CH3)3), 1.03 (t, 6H, J = 7.45, OCH2CH2CH3), 0.90 (s, 
18H, C(CH3)3), 0.11 (overlapping s, 36H, N(SiMe3)2. 13C NMR 
(CDCl3): δ = 156.3, 148.4, 145.1, 138.0, 131.2, 131.1, 124.8, 
123.3, 79.2, 32.8, 32.6, 30.9, 30.1, 29.9, 19.7, 8.2, 3.9. 
Table 3 Crystallographic data for compounds 1, 2, 3 and 6. 5 
Compound 1 2 3 6 
Formula C62H66F10O4Zn2 C52H72O4Zn2 C56H84NNaO4Si2Zn 
C126H137F15O19Zn6· 
5CH3CN 
Formula weight 1195.89 891.89 979.80 2837.84 
Crystal system Triclinic Triclinic Triclinic Triclinic 
Space group P1 P1 P1 P1 
Unit cell dimensions 
a (Å) 10.935(3) 12.4407(9) 10.0724(7) 16.9733(14) 
b (Å) 15.653(4) 13.4833(9) 12.3152(9) 20.4715(17) 
c (Å) 18.150(5) 24.1096(17) 22.8866(16) 21.2759(17) 
α (°) 95.911(4) 90.508(5) 81.897(3) 91.246(6) 
β (°) 105.236(3) 100.609(6) 88.440(3) 109.931(8) 
γ (°) 105.822(4) 113.943(7) 89.093(3) 102.477(7) 
V (Å3) 2832.4(13) 3617.2(5) 2809.3(3) 6749.0(10) 
Z 2 3 2 2 
Temperature (K) 120(2) 100(2) 100(2) 100(2) 
Dcalcd (Mg/m-3) 1.402 1.228 1.158 1.396 
Absorption coefficient, μ (mm-1) 0.869 1.036 0.530 1.135 
Crystal size (mm3) 0.18 x 0.05 x 0.02 0.050 x 0.040 x 0.020 0.18 x 0.13 x 0.05 0.11 × 0.02 × 0.01 
2θmax (°) 26.0 27.5 27.5 22.5 
Reflections measured 24992 42558 48002 60159 
Unique reflections, R int 11859, 0.042 16159, 0.075 12822, 0.039 17582, 0.340 
Reflections with F2 > 2σ(F2) 7445 11427 12053 5403 
Transmission factors (max., min.) 0.983 and 0.859 1.000 and 0.757 1.000 and 0.747 0.994 and 0.885 
Number of parameters 888 808 603 1766 
R1 [F2 > 2σ(F2)] 0.046 0.079 0.041 0.086 
wR2 (all data) 0.118 0.228 0.116 0.142 
GOOF, S 0.989 1.041 1.055 0.807 
Largest difference peak  
and hole (e Å-3) 0.387 and –0.337 2.818 and –1.586 0.901 and –0.806 0.505 and –0.448 
Synthesis of L2(ZnC6F5)3 (5) 
A toluene solution (30 ml) of p-tert-
butylhexahomotrioxacalix[3]arene (0.50 g, 0.87 mmol) and 
bis(pentafluorophenyl)zinc.toluene (1.27 g, 2.60 mmol) was 10 
stirred at ambient temperature for 12 h. The volatiles removed in 
vacuo. The residue was extracted into warm light petroleum and 
compound 5 immediately formed as a white powder. (0.91 g, 79 
%). MS (EI, m/z): 1270.2 [M]+. IR (Nujol, KBr, cm-1): 1634m, 
1608m, 1588w, 1532w, 1504s, 1394m, 1304m, 1261s, 1215s, 15 
1052s, 1023s, 974s, 954s, 925m, 915m, 878s, 828m, 799s, 771m, 
751m, 659w, 598m, 590m, 534m, 498w, 455m. Found: C, 51.12; 
H 3.63 %. C62H66F10O4Zn2 requires C, 51.03; H, 3.57 %. 1H 
NMR (CDCl3): δ = 7.20 (s, 2H, Ar-H), 7.16, 7.13 (ABq, 4H, J = 
1.91 Hz, Ar-H) 5.54 (d, 2H, J = 13.6, Ar-H), 5.54 (d, 2H, J = 20 
13.6, endo-CH2), 5.40 (d, 2H, J = 10.4, endo-CH2), 5.26 (d, 2H, 
J = 10.6, endo-CH2), 4.82 (d, 2H, J = 10.4, exo-CH2), 4.71 (d, 
2H, J = 10.6, exo-CH2), 4.51 (d, 2H, J = 13.6, exo-CH2), 1.25 (s, 
18H, C(CH3)3), 1.17 (s, 9H, C(CH3)3). 19F (CDCl3): -115.8 (m, 
4F, ArF), -116.2 (m, 2F, ArF) -155.5 (t, 2F, J = 25.0, ArF), -25 
155.6 (t, 1F, J = 25.0, ArF), -161.5 – 162.0 (m, 6F, ArF). 
Synthesis of (L2)Zn6(C6F5)(R)(RH)OH·5MeCN (6) R = 
C6F5CH2–(p-tBuPhenolate–CH2OCH2–)2–p-tBuPhenolate–
CH2O-)3- 
Compound 5 (1.0 g, 0.79 mmol) was dissolved in acetonitrile (30 30 
ml) and heated at reflux for 1 h. Clear blades of compound 6 
formed on cooling to room temperature. (0.11 g, 5.3 % yield). 
Found: C, 56.26; H 4.72. C126H137F15O19Zn6 requires C, 57.53; 
H, 4.67 %. 1H NMR (CDCl3): 7.24 (s, 2H, Ar-H), 7.18-7.14 (m, 
1H, Ar-H), 7.11-7.01 (m, 3H, Ar-H), 6.93 (d, 1H, J = 2.5, Ar-H), 35 
6.88 (d, 1H, J = 2.5, Ar-H), 6.86-6.85 (m, 1H, Ar-H), 6.77 (d, 1H, 
J = 2.45, Ar-H) 6.74 (d, 1H, J = 2.25, Ar-H), 6.70 (d, 1H, J = 
2.35, Ar-H), 6.63 (br t, 2H), 6.58 (d, 1H, J = 2.32) 6.56 (d, 1H, J 
= 2.32) 6.10-6.02 (m, 2H), 5.94-5.88 (m, 2H), 5.86-5.83 (m, 2H), 
5.73-5.67 (m, 2H), 5.58-5.55 (m, 2H), 5.31 (d, 1H, J = 9.21, 40 
endo-CH2), 4.97 (d, 1H, J = 13.7, endo-CH2), 4.90 (d, 1H, J = 
10.85), 4.85 (d, 1H, J = 13.7), 4.79 (d, 1H, J = 11.0), 4.64-4.52 
(m, 2H), 4.48 (d, 2H, J = 13.6), 4.19 (d, 2H, J = 13.6), 4.15 (d, 
1H, J = 9.45), 4.10 (d, 1H, J = 9.10), 4.07-3.96 (m, 4H), 3.88-
3.75 (m, 5H), 3.70 (d, 1H, J = 13.9), 3.63 (m, 2H), 3.55 (d, 1H, J 45 
= 10.8), 3.07 (d, 1H, J = 17.3), 2.80 (d, 1H, J = 14.5), 2.35 (s, 
2H), 2.00 (s, 6H, MeCN), 1.36 (s, 9H, C(CH3)3), 1.29 (s, 9H, 
C(CH3)3), 1.28 (s, 9H, C(CH3)3), 1.23 (s, 9H, C(CH3)3), 1.14 (s, 
9H, C(CH3)3), 1.10 (s, 9H, C(CH3)3) 0.98 (s, 9H, C(CH3)3) 0.82 
(s, 9H, C(CH3)3) 0.62 (s, 9H, C(CH3)3). 19F NMR (CDCl3): -50 
114.8 (m, 2F), -141.8 (m, 2F), -142.3 (m, 2F), -158.3 (t, 1F, J = 
21.3), -158.8 (t, 1F, J = 19.7), -160.14 (t, 1F, J = 20.9), -163.2 (m, 
2F), -163.6 (m, 2F), -164.2 (m, 2F). 
Polymerization methods 55 
ε-Caprolactone 
A Schlenk flask (250 ml) was charged with the required quantity 
of pre-catalyst in a glove box. The required amount of dry, 
degassed toluene and alcohol (from an alcohol/toluene solution) 
was added. The solution was heated to the required temperature. 60 
The polymerization was initiated by addition of the ε-
caprolactone and was stirred for the allotted time. Conversion of 
monomer was determined by 1H NMR spectroscopy, and the 
polymerization was quenched by addition of methanol 
rac-Lactide 5 
Solutions of rac-lactide and catalyst were prepared separately 
using the required solvent. The required amount of alcohol, from 
a standard alcohol solution in toluene, was added to the catalyst. 
The rac-lactide solution was added to the catalyst solution and 
stirred for the allotted time at room temperature under nitrogen. 10 
0.5 – 1.0 mL aliquots were taken out of the stirred solution where 
required and quenched with 1 drop of 0.1 M HCl. The aliquots 
were then dried and analysed by 1H NMR spectroscopy and GPC. 
Crystallography 15 
Intensity data were collected on Bruker Apex 2 CCD 
diffratometer (1) or a Rigaku FR-E+ diffractometer (all others). 
For 1, data were measured using synchrotron radiation at SRS 
Daresbury station 9.8; all other data were measured with 
monochromated Mo-Kα radiation. Structures were determined by 20 
the direct methods routines in SHELXS-97 (1, 6)21 or SIR-92 (2, 
3),22 and were refined by full-matrix least-squares methods on F2 
in SHELXL-2013/2014.21 Non-hydrogen atoms were refined with 
anisotropic displacement parameters. Hydrogen atoms were 
included in idealized positions and their U iso  values were set to 25 
ride on the Ueq values of the parent carbon atoms except for 
H(13) in 6 for which coordinates were refined with an O–H 
distance restraint. Complex 2 contained a disordered solvent 
region which was handled using the BYPASS procedure.23 
Crystal data and refinement results for all samples are collated in 30 
Table 3. CCDC 1014114-1014117 contain the supplementary 
crystallographic data for this paper. These data can be obtained 
free of charge from The Cambridge Crystallographic Data Centre 
via www.ccdc.cam.ac.uk/data_request/cif 
35 
Conclusion 
In conclusion, we have structurally characterized a number of 
new zinc complexes bearing ligands derived from either 1,3-
dipropoxy-p-tert-butyl-calix[4]arene or p-tert-
butylhexahomotrioxacalix[3]arene. These include a complex in 40 
which there are two different calixarene conformations in the 
same structure, and an unusual structure bearing an 
oxacalix[3]arene derived ligand as well as two ring-opened 
ligands  derived from the parent oxacalix[3]arene. Screening for 
the potential to ROP either ε-caprolactone (ε-CL) and rac-lactide 45 
revealed that the presence of a Zn-C6F5 motif was detrimental in 
the calix[4]arene systems, whilst use of the amide group 
N(SiMe3)2 proved to be more effective, with a 65 % conversion 
over 4 h at ambient temperature. 
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